Retatrutide, developed by Soma Pharmaceuticals , is attracting increasing attention as a potential treatment for weight management . This dual-action medication combines the properties of a GLP-1 receptor agonist and a GIP receptor stimulant, intended to not only promote metabolic improvements bu